Genome and RNA sequencing in patients with methylmalonic aciduria of unknown cause
- PMID: 31462756
- DOI: 10.1038/s41436-019-0640-9
Genome and RNA sequencing in patients with methylmalonic aciduria of unknown cause
Erratum in
-
Correction: Genome and RNA sequencing in patients with methylmalonic aciduria of unknown cause.Genet Med. 2020 Jul;22(7):1280. doi: 10.1038/s41436-020-0852-z. Genet Med. 2020. PMID: 32483295
-
Genome and RNA sequencing in patients with methylmalonic aciduria of unknown cause.Genet Med. 2022 Jan;24(1):254. doi: 10.1016/j.gim.2021.11.014. Epub 2021 Nov 22. Genet Med. 2022. PMID: 35029148 No abstract available.
Abstract
Purpose: Our laboratory has classified patients with methylmalonic aciduria using somatic cell studies for over four decades. We have accumulated 127 fibroblast lines from patients with persistent elevated methylmalonic acid (MMA) levels in which no genetic cause could be identified. Cultured fibroblasts from 26 of these patients had low [14C]propionate incorporation into macromolecules, possibly reflecting decreased methylmalonyl-CoA mutase function.
Methods: Genome sequencing (GS), copy-number variation (CNV) analysis, and RNA sequencing were performed on genomic DNA and complementary DNA (cDNA) from these 26 patients.
Results: No patient had two pathogenic variants in any gene associated with cobalamin metabolism. Nine patients had heterozygous variants of unknown significance previously identified by a next-generation sequencing (NGS) panel targeting cobalamin metabolic genes. Three patients had pathogenic changes in genes not associated with cobalamin metabolism (PCCA, EPCAM, and a 17q12 duplication) that explain parts of their phenotypes other than elevated MMA.
Conclusion: Genome and RNA sequencing did not detect any additional putative causal genetic defects in known cobalamin genes following somatic cell studies and the use of a targeted NGS panel. They did detect pathogenic variants in other genes in three patients that explained some aspects of their clinical presentation.
Keywords: RNA sequencing; cobalamin; genome sequencing; methylmalonic aciduria; vitamin B12.
References
-
- Cummings BB, Marshall JL, Tukainen T, et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med. 2017;9:386. - DOI
-
- Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. - DOI
-
- Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet. 2011;157:33–44. - DOI
-
- Chu J, Pupavac M, Watkins D, et al. Next generation sequencing of patients with mut methylmalonic aciduria: Validation of somatic cell studies and identification of 16 novel mutations. Molec Genet Metab. 2016;118:264–271. - DOI
-
- Pupavac M, Tian X, Chu J, et al. Added value of next generation gene panel analysis for patients with elevated methylmalonic acid and no clinical diagnosis following functional studies of vitamin B12 metabolism. Mol Genet Metab. 2016;117:363–368. - DOI
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
